Literature DB >> 12456637

Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function.

Johan Kreuger1, Taro Matsumoto, Maarten Vanwildemeersch, Takako Sasaki, Rupert Timpl, Lena Claesson-Welsh, Dorothe Spillmann, Ulf Lindahl.   

Abstract

The anti-angiogenic activity of endostatin (ES) depends on interactions with heparan sulfate (HS). In the present study, intact HS chains of >/=15 kDa bound quantitatively to ES whereas N-sulfated HS decasaccharides, with affinity for several fibroblast growth factor (FGF) species, failed to bind. Instead, ES-binding oligosaccharides composed of mixed N-sulfated and N-acetylated disaccharide units were isolated from pig intestinal HS. A 10/12mer ES-binding epitope was identified, with two N-sulfated regions separated by at least one N-acetylated glucosamine unit (SAS-domain). Cleavage at the N-acetylation site disrupted ES binding. These findings point to interaction between discontinuous sulfated domains in HS and arginine clusters at the ES surface. The inhibitory effect of ES on vascular endothelial growth factor-induced endothelial cell migration was blocked by the ES-binding SAS-domains and by heparin oligosaccharides (12mers) similar in length to the ES-binding SAS-domains, but not by 6mers capable of FGF binding. We propose that SAS-domains modulate the biological activities of ES and other protein ligands with extended HS-binding sites. The results provide a rational explanation for the preferential interaction of ES with certain HS proteoglycan species.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456637      PMCID: PMC136942          DOI: 10.1093/emboj/cdf638

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  Specific binding of the chemokine platelet factor 4 to heparan sulfate.

Authors:  S E Stringer; J T Gallagher
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

2.  Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis.

Authors:  J Dixelius; H Larsson; T Sasaki; K Holmqvist; L Lu; A Engström; R Timpl; M Welsh; L Claesson-Welsh
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

3.  Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.

Authors:  J Kreuger; M Salmivirta; L Sturiale; G Giménez-Gallego; U Lindahl
Journal:  J Biol Chem       Date:  2001-06-13       Impact factor: 5.157

4.  Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding.

Authors:  N Yamaguchi; B Anand-Apte; M Lee; T Sasaki; N Fukai; R Shapiro; I Que; C Lowik; R Timpl; B R Olsen
Journal:  EMBO J       Date:  1999-08-16       Impact factor: 11.598

5.  Highly sensitive sequencing of the sulfated domains of heparan sulfate.

Authors:  C L Merry; M Lyon; J A Deakin; J J Hopwood; J T Gallagher
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

6.  Cell surface glypicans are low-affinity endostatin receptors.

Authors:  S A Karumanchi; V Jha; R Ramchandran; A Karihaloo; L Tsiokas; B Chan; M Dhanabal; J I Hanai; G Venkataraman; Z Shriver; N Keiser; R Kalluri; H Zeng; D Mukhopadhyay; R L Chen; A D Lander; K Hagihara; Y Yamaguchi; R Sasisekharan; L Cantley; V P Sukhatme
Journal:  Mol Cell       Date:  2001-04       Impact factor: 17.970

7.  The proliferative and migratory activities of breast cancer cells can be differentially regulated by heparan sulfates.

Authors:  V Nurcombe; C E Smart; H Chipperfield; S M Cool; B Boilly; H Hondermarck
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

8.  Phosphoinositide 3 kinase is critical for survival, mitogenesis and migration but not for differentiation of endothelial cells.

Authors:  J H Qi; T Matsumoto; K Huang; K Olausson; R Christofferson; L Claesson-Welsh
Journal:  Angiogenesis       Date:  1999       Impact factor: 9.596

9.  Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.

Authors:  S Tessler; P Rockwell; D Hicklin; T Cohen; B Z Levi; L Witte; I R Lemischka; G Neufeld
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

10.  Molecular organization of the interferon gamma-binding domain in heparan sulphate.

Authors:  H Lortat-Jacob; J E Turnbull; J A Grimaud
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

View more
  20 in total

1.  Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Joseph Zaia
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

2.  Temporal and functional changes in glycosaminoglycan expression during osteogenesis.

Authors:  Victor Nurcombe; Fuqi Jack Goh; Larisa M Haupt; Sadasivam Murali; Simon M Cool
Journal:  J Mol Histol       Date:  2007-08-03       Impact factor: 2.611

3.  Method development and analysis of free HS and HS in proteoglycans from pre- and postmenopausal women: evidence for biosynthetic pathway changes in sulfotransferase and sulfatase enzymes.

Authors:  Wei Wei; Rebecca L Miller; Julie A Leary
Journal:  Anal Chem       Date:  2013-05-28       Impact factor: 6.986

4.  Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.

Authors:  Akulapalli Sudhakar; Hikaru Sugimoto; Changqing Yang; Julie Lively; Michael Zeisberg; Raghu Kalluri
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

5.  Heparan sulfate differences in rheumatoid arthritis versus healthy sera.

Authors:  Jenny K Sabol; Wei Wei; Marcos López-Hoyos; Youjin Seo; Armann Andaya; Julie A Leary
Journal:  Matrix Biol       Date:  2014-09-11       Impact factor: 11.583

6.  Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling.

Authors:  Nadja Jastrebova; Maarten Vanwildemeersch; Ulf Lindahl; Dorothe Spillmann
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

7.  Fibroblast growth factors share binding sites in heparan sulphate.

Authors:  Johan Kreuger; Per Jemth; Emil Sanders-Lindberg; Liat Eliahu; Dina Ron; Claudio Basilico; Markku Salmivirta; Ulf Lindahl
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

8.  The heparin-binding site of antithrombin is crucial for antiangiogenic activity.

Authors:  Weiqing Zhang; Richard Swanson; Gonzalo Izaguirre; Yan Xiong; Lester F Lau; Steven T Olson
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

9.  Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development.

Authors:  Alexandra Abramsson; Sindhulakshmi Kurup; Marta Busse; Shuhei Yamada; Per Lindblom; Edith Schallmeiner; Denise Stenzel; Dominique Sauvaget; Johan Ledin; Maria Ringvall; Ulf Landegren; Lena Kjellén; Göran Bondjers; Jin-ping Li; Ulf Lindahl; Dorothe Spillmann; Christer Betsholtz; Holger Gerhardt
Journal:  Genes Dev       Date:  2007-02-01       Impact factor: 11.361

Review 10.  Heparan sulfate biosynthesis: regulation and variability.

Authors:  Johan Kreuger; Lena Kjellén
Journal:  J Histochem Cytochem       Date:  2012-10-04       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.